1 of 1
Story summary
- Dr. Abd Agbaria and team created a $60 blood test that detects stage 2-4 lung cancer.
- The assay showed 93.1% sensitivity and 90.3% specificity in the initial study.
- Researchers used a dedicated chip and fluorescence analysis of cell-free DNA methylation patterns.
- Dr. Ari Raphael said the cheap test could aid diagnosis in low-income countries.
- A multi-center trial with 103 participants is underway in Israel and Europe, ending mid-2027.